Dysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowth

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 11, 2013, Pages 1103-1111

  Jacobs, C ^a   Coss Adame, E ^b   Attaluri, A ^a   Valestin, J ^a   Rao, S S C ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ANTRODUODENOJEJUNAL MANOMETRY; ARTICLE; BACTERIAL OVERGROWTH; CANDIDA; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG MECHANISM; DUODENUM BIOPSY; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; INTESTINAL DYSMOTILITY; INTESTINE PRESSURE; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MANOMETRY; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMALL INTESTINE; STREPTOCOCCUS; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIA; BACTERIAL INFECTIONS; COLONY-FORMING UNITS ASSAY; ENTERITIS; FEMALE; FUNGI; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; HUMANS; INTESTINE, SMALL; MALE; MIDDLE AGED; MYCOSES; PROTON PUMP INHIBITORS; RISK FACTORS; YOUNG ADULT;

EID: 84877631800     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12304     Document Type: Article

References (23)

1. Hoog CM, Lindberg G, Sjoqvist U,. Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol 2007; 7: 29.
2. Vantrappen G, Janssens J, Hellemans J, Ghoos Y,. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest 1977; 59: 1158-66.
3. Camilleri M, Bharucha AE, Di Lorenzo C, et al,. Neurogastroenterology and motility society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil 2008; 20: 1269-82.
4. Husebye E, Skar V, Hoverstad T, et al,. Abnormal intestinal patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology 1995; 109: 1078-89.
5. Laine L, Ahnen D, McClain C, et al,. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 651-68.
6. Sanduleanu S, Jonkers D, De Bruine A, et al,. Non-helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther 2001; 15: 379-88.
7. Lombardo L, Foti M, Ruggia O, Chiecchio A,. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 2010; 8: 505-8.
8. Choi YK, Kraft N, Zimmerman B, et al,. Fructose intolerance in IBS and utility of fructose-restricted diet. J Clin Gastroenterol 2008; 42: 233-8.
9. Husebye E,. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 1999; 11: 141-61.
10. Soffer EE, Thongsawat S, Ellerbroek S,. Prolonged ambulatory duodeno-jejunal manometry in humans: normal values and gender effect. Am J Gastroenterol 1998; 93: 1318-23.
11. Camilleri M, Hasler WL, Parkman HP, et al,. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology 1998; 115: 747-62.
12. Posserud I, Stotzer PO, Björnasson ES, et al,. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Neurogastroenterol Motil 2007; 56: 802-8.
13. Schulze J, Sonnenborn U,. Yeast in the gut: from commensals to infectious agents. Medicine 2009; 106: 837-42.
14. Khoshini R, Dai SC, Lezcano S, Pimentel M,. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 2001; 53: 1443-54.
15. Compare D, Pica L, Rocco A, et al,. Effects of long term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest 2011; 41: 380-6.
16. Simrén M, Stotzer P-O,. Use and abuse of hydrogen breath test. Gut 2006; 55: 297-303.
17. Choung RS, Ruff KC, Malhotra A, et al,. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther 2011; 33: 1059-67.
18. Calderone RA,. Taxonomy and biology of Candida. In:, Calderone RA, ed. Candida and Candidiasis. Washington: ASM Press, 2002; 15-27.
19. Ruhnke M,. Epidemiology of Candida albicans infections and role of non-candida-albicans yeast. Curr Drug Targ 2006; 7: 495-504.
20. Reddy BS, Gatt M, Sowdi R, et al,. Gastric colonization predisposes to septic morbidity in surgical patients: a prospective study. Nutrition 2008; 24: 632-7.
21. Kane JG, Chretien JK, Garagusi VF,. Diarrhea caused by Candida. Lancet 1976; 307: 335-6.
22. Bures J, Cyrany J, Kohoutova D, et al,. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-90.
23. Urita Y, Ishihara S, Akimoto T, et al,. Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth. World J Gastroenterol 2006; 12: 3092-5.